U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H15NO3.H2O
Molecular Weight 203.2356
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ECGONINE MONOHYDRATE

SMILES

O.CN1[C@H]2CC[C@@H]1[C@H]([C@@H](O)C2)C(O)=O

InChI

InChIKey=UGPQWACOCBWXEC-PXXJPSRFSA-N
InChI=1S/C9H15NO3.H2O/c1-10-5-2-3-6(10)8(9(12)13)7(11)4-5;/h5-8,11H,2-4H2,1H3,(H,12,13);1H2/t5-,6+,7-,8+;/m0./s1

HIDE SMILES / InChI

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C9H15NO3
Molecular Weight 185.2203
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Quantification of drugs of abuse in municipal wastewater via SPE and direct injection liquid chromatography mass spectrometry.
2010-11
Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine.
2010-03
The hydrated and anhydrous gold(III) tetrachloride salts of L-ecgonine, an important forensic toxicology marker for cocaine.
2010-01
Can cocaine use be evaluated through analysis of wastewater? A nation-wide approach conducted in Belgium.
2009-05
Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.
2009-04-28
An automated SPE/LC/MS/MS method for the analysis of cocaine and metabolites in whole blood.
2008-10-15
Alpha2-containing GABA(A) receptors are involved in mediating stimulant effects of cocaine.
2008-07
Identification of metabolites with anticancer properties by computational metabolomics.
2008-06-17
Application of discriminant analysis to differentiate between incorporation of cocaine and its congeners into hair and contamination.
2008-03-21
Tropane alkaloids as medicinally useful natural products and their synthetic derivatives as new drugs.
2008-02-03
Abstracts of papers presented at the 2008 pittsburgh conference.
2008
Cocaine and metabolites urinary excretion after controlled smoked administration.
2007-10
Bioanalytical procedures for determination of drugs of abuse in blood.
2007-08
Cocaine profiling for strategic intelligence purposes, a cross-border project between France and Switzerland. Part I. Optimisation and harmonisation of the profiling method.
2007-04-11
Rapid analysis of benzoylecgonine in urine by fast gas chromatography-mass spectrometry.
2006-10
Relationships between concentrations of cocaine and its hydrolysates in peripheral blood, heart blood, vitreous humor and urine.
2006-03
Simultaneous analyses of cocaine, cocaethylene, and their possible metabolic and pyrolytic products.
2006-02-10
Concentration profiles of cocaine, pyrolytic methyl ecgonidine and thirteen metabolites in human blood and urine: determination by gas chromatography-mass spectrometry.
2005-11
Gender differences in cocaine pharmacokinetics in CF-1 mice.
2005-01-15
Determination of cocaine, its metabolites, pyrolysis products, and ethanol adducts in postmortem fluids and tissues using Zymark automated solid-phase extraction and gas chromatography-mass spectrometry.
2004-07-05
Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody.
2004-01-01
Determination of the dermal penetration of esterom components using microdialysis sampling.
2003-11
Determination of the highest no-effect dose (HNED) and of the elimination pattern for cocaine in horses.
2002-03-29
Synthesis and dopamine transporter binding of 2beta-isopropyl ester analogs of cocaine.
2002-02
2'-substituted analogs of cocaine: synthesis and dopamine transporter binding potencies.
2001-09
Analysis of cocaine, benzoylecgonine, ecogonine methyl ester, and ecgonine by high-pressure liquid chromatography-API mass spectrometry and application to a short-term degradation study of cocaine in plasma.
2001-09
A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis.
2001-06
Ecgonine is an important marker for cocaine use in inadequately preserved specimens.
2001-04
In vitro stability of cocaine in whole blood and plasma including ecgonine as a target analyte.
2001-04
Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs.
1997-09
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:08:44 GMT 2025
Edited
by admin
on Mon Mar 31 18:08:44 GMT 2025
Record UNII
ET3PMG0528
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ECGONINE MONOHYDRATE
MI  
Common Name English
ECGONINE MONOHYDRATE [MI]
Preferred Name English
(1R,2R,3S,5S)-3-HYDROXY-8-METHYL-8-AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLIC ACID MONOHYDRATE
Systematic Name English
8-AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLIC ACID, 3-HYDROXY-8-METHYL-, MONOHYDRATE, (1R-(EXO,EXO))-
Systematic Name English
Code System Code Type Description
MERCK INDEX
m4810
Created by admin on Mon Mar 31 18:08:44 GMT 2025 , Edited by admin on Mon Mar 31 18:08:44 GMT 2025
PRIMARY Merck Index
PUBCHEM
70269372
Created by admin on Mon Mar 31 18:08:44 GMT 2025 , Edited by admin on Mon Mar 31 18:08:44 GMT 2025
PRIMARY
FDA UNII
ET3PMG0528
Created by admin on Mon Mar 31 18:08:44 GMT 2025 , Edited by admin on Mon Mar 31 18:08:44 GMT 2025
PRIMARY
CAS
5796-30-5
Created by admin on Mon Mar 31 18:08:44 GMT 2025 , Edited by admin on Mon Mar 31 18:08:44 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
ANHYDROUS->SOLVATE
Related Record Type Details
ACTIVE MOIETY